Dosidal · Italy

it:authorisation:050359

Dosidal is a product record. It identifies a medicine and its regulatory status. It does not advise on use.

MarketItaly
Recordit:authorisation:050359 (version 1)
Levelauthorisation
Pack codenot anchored
Identifiersaic-medicine: 050359
Source authorityAIFA
Read date
identityatc: L01FY02
holder: BRISTOL-MYERS SQUIBB PHARMA EEIG
medicine: OPDUALAG
medicine_code: 050359
procedure: Procedura Centralizzata
substances: NIVOLUMAB/RELATLIMAB
state: current · read 2026-11-15T12:14:32Z · source: AIFA (open data) page
SignatureES256 over JCS, key dosidal-record-1.9dbf5d53
hYummUVc5xg0M70K4ZDgaAeDJMUvNLPa6ii0GZxVX7ywbqVMmtEpphQH5U4MpUe-GagpYvKi-LzDxbg98ArHVA
Verify with verify_record (MCP) or POST https://dosidal-api.ai/v1/verify/record; keyring https://dosidal-registry.ai/.well-known/jwks.json

JSON: https://dosidal-api.ai/v1/records/it:authorisation:050359 · Related records in other markets · Dosidal